Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medi-Cal

Executive Summary

Has signed at least 50 contracts with drug manufacturers to provide "additional rebates" under California's budget rescue package. Those include about eight to 10 contract amendments from firms who had rebate contracts directly with the California Medicaid agency rather than HCFA plus roughly 40 other contracts. At least four companies -- Merck, Lilly, Upjohn and Pfizer -- initially informed Medi-Cal that they would not provide the added rebates ("The Pink Sheet" Oct. 5, p. 3). Medi-Cal subsequently has met with all firms that declined. The state does not consider anyone out of the program yet. Eventually, products from firms that do not meet minimum rebate levels will be covered by Medi-Cal only on a prior-authorization basis.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021808

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel